Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Anele CC, Adegbola SO, Askari A et al (2017) Risk of metachronous colorectal cancer following colectomy in lynch syndrome: a systematic review and meta-analysis. Colorectal Dis 19(6):528–536. https://doi.org/10.1111/codi.13679

Renkonen-Sinisalo L, Seppala TT, Jarvinen HJ et al (2017) Subtotal colectomy for colon cancer reduces the need for subsequent surgery in lynch syndrome. Dis Colon Rectum 60(8):792–799. https://doi.org/10.1097/DCR.0000000000000802

Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP et al (2012) Quality of life after surgery for colon cancer in patients with lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum 55(6):653–659. https://doi.org/10.1097/DCR.0b013e31824f5392

Moertel CG, Bargen JA, Dockerty MB (1958) Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases. Gastroenterology 34(1):85–98

Bouvier AM, Latournerie M, Jooste V et al (2008) The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 44(4):522–527. https://doi.org/10.1016/j.ejca.2008.01.007

Kohlmann W, GS lynch syndrome. 2004 Feb 5 [Updated 2018 Apr 12]. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews® [Internet]. Seattle: University of Washington

Signoroni S, Tibiletti MG, Ricci MT et al (2019) Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: a retrospective single-center study. Tumori 105(1):76–83. https://doi.org/10.1177/0300891618792460

Vasen HF, Moslein G, Alonso A et al (2010) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9(2):109–115. https://doi.org/10.1007/s10689-009-9291-3

Lynch HT, Lanspa S, Smyrk T et al (1991) Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control Part I. Cancer Genet Cytogenet 53(2):143–160

Provenzale D, Gupta S, Ahnen DJ et al (2018) NCCN guidelines insights: colorectal cancer screening, version 1.2018. J Natl Compr Canc Netw 16(8):939–949. https://doi.org/10.6004/jnccn.2018.0067

Bonadona V, Bonaiti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304–2310. https://doi.org/10.1001/jama.2011.743

Vasen HF, Blanco I, Aktan-Collan K et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823. https://doi.org/10.1136/gutjnl-2012-304356

Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262. https://doi.org/10.1038/ajg.2014.435

Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol 13(10):1296–1321. https://doi.org/10.1245/s10434-006-9036-6

Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Am J Gastroenterol 109(8):1159–1179. https://doi.org/10.1038/ajg.2014.186

Heneghan HM, Martin ST, Winter DC (2015) Segmental vs extended colectomy in the management of hereditary nonpolyposis colorectal cancer: a systematic review and meta-analysis. Colorectal Dis 17(5):382–389. https://doi.org/10.1111/codi.12868

Malik SS, Lythgoe MP, McPhail M et al (2018) Metachronous colorectal cancer following segmental or extended colectomy in lynch syndrome: a systematic review and meta-analysis. Fam Cancer 17(4):557–564. https://doi.org/10.1007/s10689-017-0062-2

Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268. https://doi.org/10.1093/jnci/djh034

Clark SK (2019) Management of genetically determined colorectal cancer. Surgeon 17(3):165–171. https://doi.org/10.1016/j.surge.2019.03.003

Kumarasinghe AP, de Boer B, Bateman AC et al (2010) DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material. Pathology 42(5):414–420. https://doi.org/10.3109/00313025.2010.493862

Shia JSZ, Weiser MR (2011) Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol 35(3):447–454

Piozzi GN, Ricci MT, Signoroni S et al (2019) Ready, get set, go: fast preoperative genetic diagnosis is the present future in lynch syndrome surgical strategy. Dig Liver Dis. https://doi.org/10.1016/j.dld.2019.09.021

Moller P, Seppala T, Bernstein I et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective lynch syndrome database. Gut 66(3):464–472. https://doi.org/10.1136/gutjnl-2015-309675

Kohlmann W, Gruber SB (1993) Lynch syndrome. In: Adam MP, Ardinger HH, Pagon RA et al. (eds) GeneReviews((R)). Seattle

Parry S, Win AK, Parry B et al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60(7):950–957. https://doi.org/10.1136/gut.2010.228056

Win AK, Parry S, Parry B et al (2013) Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 20(6):1829–1836. https://doi.org/10.1245/s10434-012-2858-5

Bogani G, Ricci MT, Vitellaro M et al (2019) Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in lynch syndrome. Int J Gynecol Cancer 29(4):705–710. https://doi.org/10.1136/ijgc-2019-000277

Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834

de Jong AE, Hendriks YM, Kleibeuker JH et al (2006) Decrease in mortality in lynch syndrome families because of surveillance. Gastroenterology 130(3):665–671. https://doi.org/10.1053/j.gastro.2005.11.032

Seppala TT, Ahadova A, Dominguez-Valentin M et al (2019) Lack of association between screening interval and cancer stage in lynch syndrome may be accounted for by over-diagnosis; a prospective lynch syndrome database report. Hered Cancer Clin Pract 17:8. https://doi.org/10.1186/s13053-019-0106-8

Engel C, Vasen HF, Seppala T et al (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different lynch syndrome surveillance policies. Gastroenterology 155(5):1400–1409. https://doi.org/10.1053/j.gastro.2018.07.030

Mecklin JP, Jarvinen HJ (1986) Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum 29(3):160–164

Jiang B, Ofshteyn A, Idrees JJ et al (2019) Total abdominal colectomy is cost-effective in treating colorectal cancer in patients with genetically diagnosed lynch syndrome. Am J Surg. https://doi.org/10.1016/j.amjsurg.2019.03.011

Ricci MT, Volorio S, Signoroni S et al (2019) Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis. Tumori. https://doi.org/10.1177/0300891619847085

Dominguez-Valentin M, Sampson JR, Seppala TT et al (2019) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective lynch syndrome database. Genet Med. https://doi.org/10.1038/s41436-019-0596-9